(Q28253200)

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Prevalence and significance of prostatic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

NIH consensus definition and classification of prostatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Measurement of pyuria and its relation to bacteriuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Classification (traditional and National Institutes of Health) and demographics of prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Diagnosis and treatment of prostatic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Antimicrobial therapy for bacterial and nonbacterial prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Bacterial prostatitis in patients infected with the human immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Bacterial prostatitis: new methods of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median followup of 30 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Chronic bacterial prostatitis treated with intraprostatic injection of antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Prostatitis syndromes: new perspectives about old woes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Regional morphology and pathology of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Urinary tract infection in urology, including acute and chronic prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Bladder training biofeedback and pelvic floor myalgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X

The role of cytokines in prostatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900169-X